- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- December 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 216 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 179 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 250 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Report
- March 2025
- 186 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- February 2025
- 120 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
From €4389EUR$4,900USD£3,741GBP
- Report
- February 2025
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 222 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- April 2025
- 20 Pages
Global
From €13431EUR$14,995USD£11,449GBP
- Report
- March 2025
- 114 Pages
Global
From €13431EUR$14,995USD£11,449GBP
- Report
- December 2024
- 34 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Clinical Trials
- April 2025
- 1432 Pages
Global
From €3090EUR$3,450USD£2,634GBP

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more